The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review

BACKGROUND: The use of immune-checkpoint inhibitors in cancer treatment has become increasingly common, resulting in an increase in the incidence of related side effects. Diarrhoea and colitis have been previously documented as gastrointestinal tract-related side effects of immune-checkpoint inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Ryosuke, Araki, Toshihiro, Mitsuyama, Keiichi, Tokito, Takaaki, Ishii, Hidenobu, Yoshioka, Shinichiro, Kuwaki, Kotaro, Mori, Atsushi, Yoshimura, Tetsuhiro, Tsuruta, Osamu, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119262/
https://www.ncbi.nlm.nih.gov/pubmed/30170560
http://dx.doi.org/10.1186/s12876-018-0864-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119262/
https://www.ncbi.nlm.nih.gov/pubmed/30170560
http://dx.doi.org/10.1186/s12876-018-0864-1

Ejemplares similares